Skip to main content
Erschienen in: Metabolic Brain Disease 1/2019

15.11.2018 | Original Article

Establishment and evaluation of a model for predicting 3-month mortality in Chinese patients with hepatic encephalopathy

verfasst von: Yanping Cui, Shan Guan, Jie Ding, Yukai He, Qingfang Li, Sikui Wang, Huiling Sun

Erschienen in: Metabolic Brain Disease | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Hepatic encephalopathy (HE) is a serious complication of liver disease. To establish a model for predicting 3-month mortality in patients with HE in China. This retrospective study included 609 patients with HE admitted to the Peoples’ Hospital, Liaocheng City, China (August 2006 to January 2016). Patients were allocated to a modeling (n = 409) or validation (n = 200) group. Demographic/clinical characteristics, laboratory test results, Model for End Stage Liver Disease (MELD) score and Child-Turcotte-Pugh (CTP) score were extracted from medical records. A model for predicting death within 3 months after admission was established using logistic regression analysis (modeling group). Model validity (validation group) was assessed using receiver operating characteristic (ROC) curve analysis. 270/409(66.0%) patients died in the modeling group and 142/203(70.0%) died in the validation group. Compared with survivors, patients who died had more severe HE, and higher MELD score, CTP score, incidence of complications including hepatorenal syndrome (HRS) and upper gastrointestinal bleeding, and values for laboratory parameters including red blood cell count(RBC) and total bilirubin(TBIL)(P < 0.05). Regression analysis revealed RBC, TBIL, HE stage, HRS and upper gastrointestinal bleeding as independent factors associated with death (P < 0.05). The area under the ROC curve (AUC) for the model was 0.931.The model had a higher Youden index than MELD or CTP scores and predicted death in the validation group with a sensitivity of 83.1% and specificity of 93.4%. The established model has superior performance to MELD and CTP scores for predicting mortality in patients with HE.
Literatur
Zurück zum Zitat Attia KA, Ackoundou-N'guessan KC, N'Dri-Yoman AT, Mahassadi AK, Messou E, Bathaix YF, Kissi YH (2008) Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. World J Gastroenterol 14:286–291CrossRefPubMedPubMedCentral Attia KA, Ackoundou-N'guessan KC, N'Dri-Yoman AT, Mahassadi AK, Messou E, Bathaix YF, Kissi YH (2008) Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients. World J Gastroenterol 14:286–291CrossRefPubMedPubMedCentral
Zurück zum Zitat Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R (2003) MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 52:134–139CrossRefPubMedPubMedCentral Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R (2003) MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 52:134–139CrossRefPubMedPubMedCentral
Zurück zum Zitat Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodes J (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890–895CrossRefPubMed Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, Rodes J (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890–895CrossRefPubMed
Zurück zum Zitat Chinese Society of Gastroenterology, Chinese Society of Hepatology CMA, Chinese Medical Association (2013) Consensus on the diagnosis and treatment of hepatic encephalopathy. Zhonghua Gan Zang Bing Za Zhi 21:641–651 Chinese Society of Gastroenterology, Chinese Society of Hepatology CMA, Chinese Medical Association (2013) Consensus on the diagnosis and treatment of hepatic encephalopathy. Zhonghua Gan Zang Bing Za Zhi 21:641–651
Zurück zum Zitat Christensen E, Krintel JJ, Hansen SM, Johansen JK, Juhl E (1989) Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. Scand J Gastroenterol 24:999–1006CrossRefPubMed Christensen E, Krintel JJ, Hansen SM, Johansen JK, Juhl E (1989) Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. Scand J Gastroenterol 24:999–1006CrossRefPubMed
Zurück zum Zitat Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial Gastroenterology 72:573–583PubMed Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial Gastroenterology 72:573–583PubMed
Zurück zum Zitat Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649CrossRefPubMed Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649CrossRefPubMed
Zurück zum Zitat Saunders JB, Walters JR, Davies AP, Paton A (1981) A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 282:263–266CrossRef Saunders JB, Walters JR, Davies AP, Paton A (1981) A 20-year prospective study of cirrhosis. Br Med J (Clin Res Ed) 282:263–266CrossRef
Zurück zum Zitat Simon-Talero M, Garcia-Martinez R, Torrens M, Augustin S, Gomez S, Pereira G, Guevara M, Gines P, Soriano G, Roman E, Sanchez-Delgado J, Ferrer R, Nieto JC, Sunye P, Fuentes I, Esteban R, Cordoba J (2013) Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol 59:1184–1192. https://doi.org/10.1016/j.jhep.2013.07.020 CrossRefPubMed Simon-Talero M, Garcia-Martinez R, Torrens M, Augustin S, Gomez S, Pereira G, Guevara M, Gines P, Soriano G, Roman E, Sanchez-Delgado J, Ferrer R, Nieto JC, Sunye P, Fuentes I, Esteban R, Cordoba J (2013) Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol 59:1184–1192. https://​doi.​org/​10.​1016/​j.​jhep.​2013.​07.​020 CrossRefPubMed
Zurück zum Zitat Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P (2014) Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the liver. Hepatology 60:715–735. https://doi.org/10.1002/hep.27210 CrossRefPubMed Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P (2014) Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the liver. Hepatology 60:715–735. https://​doi.​org/​10.​1002/​hep.​27210 CrossRefPubMed
Zurück zum Zitat Vlachogiannakos J, Kougioumtzian A, Triantos C, Viazis N, Sgouros S, Manolakopoulos S, Saveriadis A, Markoglou C, Economopoulos T, Karamanolis DG (2007) Clinical trial: the effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices. Aliment Pharmacol Ther 26:1479–1487. https://doi.org/10.1111/j.1365-2036.2007.03539.x CrossRefPubMed Vlachogiannakos J, Kougioumtzian A, Triantos C, Viazis N, Sgouros S, Manolakopoulos S, Saveriadis A, Markoglou C, Economopoulos T, Karamanolis DG (2007) Clinical trial: the effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices. Aliment Pharmacol Ther 26:1479–1487. https://​doi.​org/​10.​1111/​j.​1365-2036.​2007.​03539.​x CrossRefPubMed
Zurück zum Zitat Weissenborn K, Bokemeyer M, Krause J, Ennen J, Ahl B (2005) Neurological and neuropsychiatric syndromes associated with liver disease. Aids 19(Suppl 3):S93–S98CrossRefPubMed Weissenborn K, Bokemeyer M, Krause J, Ennen J, Ahl B (2005) Neurological and neuropsychiatric syndromes associated with liver disease. Aids 19(Suppl 3):S93–S98CrossRefPubMed
Zurück zum Zitat Yoneyama K, Nebashi Y, Kiuchi Y, Shibata M, Mitamura K (2004) Prognostic index of cirrhotic patients with hepatic encephalopathy with and without hepatocellular carcinoma. Dig Dis Sci 49:1174–1180CrossRefPubMed Yoneyama K, Nebashi Y, Kiuchi Y, Shibata M, Mitamura K (2004) Prognostic index of cirrhotic patients with hepatic encephalopathy with and without hepatocellular carcinoma. Dig Dis Sci 49:1174–1180CrossRefPubMed
Metadaten
Titel
Establishment and evaluation of a model for predicting 3-month mortality in Chinese patients with hepatic encephalopathy
verfasst von
Yanping Cui
Shan Guan
Jie Ding
Yukai He
Qingfang Li
Sikui Wang
Huiling Sun
Publikationsdatum
15.11.2018
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 1/2019
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-018-0333-0

Weitere Artikel der Ausgabe 1/2019

Metabolic Brain Disease 1/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.